Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Letter

Clin Cancer Res. 2019 Jun 1;25(11):3468. doi: 10.1158/1078-0432.CCR-18-3740. Epub 2018 Dec 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • CTLA-4 Antigen
  • Forkhead Transcription Factors
  • Humans
  • Immunotherapy
  • Neoplasms*
  • T-Lymphocytes, Regulatory*

Substances

  • CTLA-4 Antigen
  • FOXP3 protein, human
  • Forkhead Transcription Factors